Autologous lymphokine-activated killer (LAK) cell therapy of EBV+ and EBV- lymphoproliferative disorders arising in organ transplant recipients

Nalesnik, MA and Rao, AS and Furukawa, H and Pham, S and Zeevi, A and Fung, JJ and Klein, G and Gritsch, A and Elder, E and Whiteside, TL and Starzl, TE (1997) Autologous lymphokine-activated killer (LAK) cell therapy of EBV+ and EBV- lymphoproliferative disorders arising in organ transplant recipients. Transplantation, 63. 1200 - 1205. ISSN 0041-1337

Preview	PDF Accepted Version Available under License : See the attached license file. Download (1MB) | Preview
	Plain Text (licence) Available under License : See the attached license file. Download (1kB)

---

Share

Citation/Export:	Select format... Citation - Text Citation - HTML Endnote BibTex Dublin Core OpenURL MARC (ISO 2709) METS MODS EP3 XML Reference Manager Refer
Social Networking:	Share |

---

Details

Item Type:	Article
Status:	Published
Creators/Authors:	Creators Email Pitt Username ORCID Nalesnik, MA Rao, AS Furukawa, H Pham, S Zeevi, A Fung, JJ Klein, G Gritsch, A Elder, E Whiteside, TL Starzl, TE tes11@pitt.edu TES11
Centers:	Other Centers, Institutes, Offices, or Units > Thomas E. Starzl Transplantation Institute
Date:	1997
Date Type:	Publication
Journal or Publication Title:	Transplantation
Volume:	63
Page Range:	1200 - 1205
Institution:	University of Pittsburgh
Refereed:	Yes
ISSN:	0041-1337
Other ID:	uls-drl:31735062134212, Starzl CV No. 1964
Date Deposited:	08 Apr 2010 17:33
Last Modified:	31 Jul 2020 18:58
URI:	http://d-scholarship.pitt.edu/id/eprint/5350

---

Metrics

Monthly Views for the past 3 years

Plum Analytics

---

Actions (login required)

View Item